Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
national_resilience [2022/08/25 18:23] pamela [Gain of Function Criticism] | — (current) | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== National Resilience ====== | ||
- | |||
- | The [[mRNA]] used in [[Moderna]]' | ||
- | |||
- | Reinventing biomanufacturing’{{ :: | ||
- | |||
- | National Resilience was founded relatively recently, in November 2020, and describes itself as “a manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.” | ||
- | |||
- | It has since been building “a sustainable network of high-tech, end-to-end manufacturing solutions with the aim to ensure the medicines of today and tomorrow can be made quickly, safely and at scale.” | ||
- | |||
- | It further plans to “reinvent biomanufacturing” and “democratize access to medicines, | ||
- | |||
- | ==== History 2020 ==== | ||
- | |||
- | Preparing for tomorrow, today. We believe the future can’t wait. That’s why we’re building Resilience to be here when you need us, ready to make important new medicines or respond to a global health crisis. We are the next generation of life science manufacturing. | ||
- | Resilience was born to address two defining challenges. 1. Manufacturing supply chains are needed that can withstand disruptive shocks and safeguard health security. 2. Biopharmaceutical manufacturing has not kept pace with scientific advancement, | ||
- | |||
- | Resilience is creating a first-of-its-kind ecosystem for advanced biopharmaceutical manufacturing. We provide a network of high-tech, end-to-end manufacturing and development solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. | ||
- | |||
- | We continuously invest in R&D for next generation manufacturing and development, | ||
- | |||
- | Through manufacturing that’s faster, safer, and more flexible, we safeguard the quality of important medicines and protect the resilience of a vital supply chain. ((https:// | ||
- | |||
- | ==== Biotech Brigade One Stop Shopping from Inception ==== | ||
- | Resilience offers a broad mix of customized manufacturing and development capabilities to serve the needs of biopharmaceutical companies at all stages of the drug development process – from pre-clinical development to commercial supply. ((https:// | ||
- | |||
- | |||
- | |||
- | ==== Meet the Team ==== | ||
- | |||
- | Board of Directors is who's who list of kingpins from intelligence to big pharma full text list needed but sample pic. | ||
- | {{ :: | ||
- | |||
- | ((https:// | ||
- | |||
- | === Board of Directors === | ||
- | |||
- | [[:Robert Nelsen]] Chairman, Resilience Founder ARCH | ||
- | |||
- | [[:Patrick Y. Yang]], PhD Vice Chairman, Former EVP Juno, [[:Roche]], [[: | ||
- | |||
- | [[:Rahul Singhvi]], ScD Co-founder, CEO | ||
- | |||
- | [[:Frances Arnold]], PhD Nobel Prize Laureate, [[: | ||
- | |||
- | [[:George Barrett]] Former Chairman & CEO, [[:Cardinal Health]] | ||
- | |||
- | [[:Mitchell E. Daniels]], Jr. President, [[:Purdue University]], | ||
- | |||
- | [[:Chris Darby]] CEO, [[: | ||
- | |||
- | [[:Susan Desmond-Hellmann]], | ||
- | |||
- | [[:Kaye Foster]] HR Executive | ||
- | |||
- | [[:Scott Gottlieb M.D.]] Partner, NEA, Former Commissioner, | ||
- | ( note - Scott Gottlieb was elected as an independent member of the board of directors of [[: | ||
- | |||
- | [[:Joseph Robert Kerrey]] - Allen & Co, Former United States [[: | ||
- | (Kerrey led official 9-11 Report Committee that never mentions WTC7 or other anomalies a whitewash at its best) ((https:// | ||
- | |||
- | [[:Drew Oetting]] Co-founder & President, 8VC Co-founder [[: | ||
- | |||
- | [[:Denice Torres]] CEO, [[:Ignited Group]], Former CEO, [[:Johnson & Johnson]]; [[:McNeil]] | ||
- | |||
- | |||
- | === Executive Team === | ||
- | |||
- | |||
- | Rahul Singhvi, SC.D. Co-founder, CEO | ||
- | |||
- | Sandy Mahatme, LLM President, COO & CFO | ||
- | |||
- | Patrick Y. Yang, PhD Vice Chairman | ||
- | |||
- | Viet Nguyen Chief Manufacturing Officer | ||
- | |||
- | Syed T. Husain | ||
- | |||
- | Georgeta Puscalau | ||
- | |||
- | Rich Stoner, PhD Chief Scientific Officer | ||
- | |||
- | Elliot Menschik, MD, PhD Chief Digital Officer | ||
- | |||
- | Ori Solomon | ||
- | |||
- | Mara Strandlund | ||
- | |||
- | Alex Szidon, PhD Chief Business Officer | ||
- | |||
- | |||
- | === Advisors === | ||
- | |||
- | [[:Charlie Cooney]], PhD Professor, [[:MIT]], Technical Advisory Board Chair | ||
- | |||
- | [[:Beverly L. Davidson]], PhD Chief Scientific Strategy Officer, The [[: | ||
- | |||
- | [[:Mark Mcclellan]], | ||
- | |||
- | |||
- | ==== Curious Domain History ==== ((https:// | ||
- | |||
- | {{ :: | ||
- | |||
- | 1997 - Now you can get true 24-hour, 365-day availability and continuous processing from a SPARC-based system. Resilient® Resilient fault tolerant SPARC systems keep your critical Solaris applications - Internet/ | ||
- | |||
- | |||
- | 2016 - We build defense-in-depth solutions for customers with zero tolerance for security breaches, violations, or attacks. Wireless threats evolve quickly and often just beyond the edge of your network. Resilience RadioSleuth™ is the industry’s most advanced wireless intrusion prevention system, continuously scanning all wireless bands to detect and mitigate wireless threats before they get beyond your outer perimeter.((https:// | ||
- | |||
- | 2020 - Resilience is changing the way medicine is made – leveraging innovation to better serve scientific discovery, withstand disruptive events, and reach those in need. {{ :: | ||
- | |||
- | We’re bringing together brilliant minds in science and engineering with the most advanced technologies to build a resilient tomorrow, today.((https:// | ||
- | |||
- | ==== Gain of Function Criticism ==== | ||
- | |||
- | August 23, 2022 Company Linked to CIA Now Making mRNA for [[: | ||
- | |||
- | Since late last year, messenger RNA for Moderna’s [[:COVID-19 vaccines]], including its recently reformulated Omicron booster, has been exclusively manufactured by National Resilience, a little-known company with significant ties to US intelligence. | ||
- | By Whitney Webb | ||
- | |||
- | |||
- | The company initially marketed its manufacturing capabilities as “the Resilience platform, | ||
- | |||
- | It is worth noting that, to date, many controversial “gain-of-function” experiments have justified modifying viruses for the same purposes as described by National Resilience’s Virus Production capabilities. | ||
- | |||
- | In addition, National Resilience offers product formulations and other modalities, such as biologics and cell therapies, to its clientele and the “Virus Production” of its website has since been removed. ((https:// |